Instrumental Respiratory Physiotherapy in Difficult-to-wean ICU Patients
PHYSIO WEAN
Randomized Controlled Trial Evaluating the Impact of Intensive, Instrumental and Early Respiratory Physiotherapy on Peak Expiratory Flow in Mechanically Ventilated Patients With ICU-acquired Muscle Weakness
2 other identifiers
interventional
50
1 country
3
Brief Summary
Difficult ventilatory weaning is associated with a 20% mortality rate. 40% of these patients will develop intensive care unit (ICU)-acquired neuromyopathy, associated with reduced cough strength and a 4-fold increase in the risk of reintubation. The objective measure of cough strength is peak expiratory flow (PEF). Instrument-assisted coughing is a respiratory physiotherapy technique capable of significantly increasing PEF in chronic neuromuscular patients and draining bronchial secretions. The objective of the study is to determine whether an early, systematic, instrumental, intensive respiratory physiotherapy strategy in patients with difficult ventilatory weaning and ICU-acquired neuromyopathy significantly improves PEF immediately prior to extubation, compared with a conventional, protocolized management strategy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 3, 2024
CompletedFirst Posted
Study publicly available on registry
July 12, 2024
CompletedStudy Start
First participant enrolled
March 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
January 20, 2026
January 1, 2026
2 years
July 3, 2024
January 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Unassisted peak expiratory cough flow (PECF) under mechanical ventilation during a voluntary coughing effort
PECF measured on the ventilator using its built-in flowmeter (PECF on unassisted coughing under mechanical ventilation). PECF is expressed in L/min.
At Hour 24
Secondary Outcomes (12)
Unassisted PECF after disconnection from mechanical ventilation during a voluntary coughing effort
At Hour 24, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7
Assisted PECF under mechanical ventilation
At Hour 24, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7
Semi-quantitative measurement of cough strength
At Hour 24, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7
Semi-quantitative measurement of cough strength
At Hour 24, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7
Semi-quantitative measurement of bronchial secretion quantity
At Hour 24, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7
- +7 more secondary outcomes
Study Arms (2)
Intensive instrumental and early respiratory physiotherapy
EXPERIMENTALPatients in this arm will receive instrumental and intensive respiratory physiotherapy strategy from inclusion to day 7, 3 times a day, before and after extubation. Instrumental physiotherapy will be protocolized and cough strength and efficacy of bronchial secretions clearance will be evaluated
Protocolized standard-of-care respiratory physiotherapy
ACTIVE COMPARATORPatients in this group will receive standardized and protocolized respiratory physiotherapy, i.e. 1 to 2 sessions of manual respiratory physiotherapy (not assisted by an instrumental technique) per day until the day of successful extubation, or until day 7 if necessary.
Interventions
Patients in this group will receive standardized and protocolized respiratory physiotherapy to reproduce the usual practices of non-expert centers,1 to 2 sessions of manual respiratory physiotherapy (not assisted by an instrumental technique) per day until the day of successful extubation, or until day 7 if necessary
Patients randomized to this group will receive 3 sessions per day of intensive early respiratory physiotherapy with instrumental techniques from randomization to day 7, before and after any extubation. The strategy will be applied until day 7 of randomization, regardless of the patient's status (intubated or not).
Eligibility Criteria
You may qualify if:
- Patient 18 years or more, affiliated to a social security system
- Patients on invasive mechanical ventilation for 48 hours or more
- Failure of at least one mechanical ventilation weaning test (spontaneous breathing trial, SBT)
- First successful SBT on the day of eligibility assessment
- Medical Research Council (MRC) score \< 48 and/or cough strength ≤ 2 on the 6-point Likert scale
You may not qualify if:
- Recent brain injury (\< 3 months, stroke, cardiopulmonary arrest)
- Delirium tremens (Cushman score \> 7)
- Chronic neuromuscular pathology
- Patient under continuous intravenous sedation
- Patient unresponsive to simple commands and Richmond Agitation and Sedation Scale (RASS) score \< -2 or \> +1
- FiO2: Inspired Oxygen Fraction\> 50%, percutaneous, O2: oxygen saturation \< 88%, positive end-expiratory pressure \> 5 centimeter of water (cmH2O) or respiratory rate ≥ 35 min-1
- Vasopressor catecholamine at a dose \> 0.5 μg/kg/min
- Tracheostomized patient
- Undrained pneumothorax
- Pulmonary emphysema (identified as antecedent in medical record)
- Uncontrolled hemoptysis
- Surgery \< 3 months of esophagus and/or the ear, nose and throat (ENT) sphere
- Pregnancy or lactating
- Patient deprived of liberty by judicial or administrative decision
- Patient under guardianship or curatorship
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Service d'Anesthésie et Réanimation, Hôpital de la Croix Rousse, GHN
Lyon, France, 69004, France
Médecine Intensive - Réanimation, Hôpital de la Croix Rousse
Lyon, 69004, France
Département d'Anesthésie Réanimation - Médecine Intensive, Centre Hospitalier Lyon Sud
Lyon, 69495, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 3, 2024
First Posted
July 12, 2024
Study Start
March 18, 2025
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
May 1, 2027
Last Updated
January 20, 2026
Record last verified: 2026-01